Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ONCOPROTNET

Financiado

Cerrado

Dynamic protein interaction networks in cancer

The inappropriate activity of signaling pathways and activation of gene-expression programs is a primary driver of transformation in cancer cells. In turn, dis-regulation of signaling pathways in cancer cells is frequently caused... ver más

31/07/2017

SOUTHAMPTON

100K€

Presupuesto del proyecto: 100K€

Líder del proyecto

UNIVERSITY OF SOUTHAMPTON No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2017-07-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

SOUTHAMPTON

0.00€ | Lider

Proyectos interesantes

DPI2015-68982-R

Medical Technol...

Data Science

118K€ Cerrado

SAF2012-35181

Medical Technol...

Data Science

445K€ Cerrado

PC INTERACTOME

Medical Technol...

Data Science

242K€ Cerrado

CANOMICS

Medical Technol...

Data Science

86K€ Cerrado

PROTBIOFLUID

Medical Technol...

Data Science

355K€ Cerrado

CTCPROTEOMIC

Medical Technol...

Data Science

200K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

UNIVERSITY OF SOUTHAMPTON No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 100K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The inappropriate activity of signaling pathways and activation of gene-expression programs is a primary driver of transformation in cancer cells. In turn, dis-regulation of signaling pathways in cancer cells is frequently caused by mutations in important oncoproteins, which may alter protein expression, structure or function. In addition, increasing evidence shows that oncoprotein mutations may alter the interactions of oncoproteins with other proteins, causing wide-spread perturbations to the network of proteins in the cell. Although high-throughput sequencing techniques are rapidly identifying large volumes of mutations from tumor samples, our understanding of how these mutations transform cancer cells, and more specifically how they perturb protein-protein interactions is lagging behind. This proposal describes novel proteomics and computational techniques directed at understanding how mutations in important oncoproteins disrupt or alter protein-protein interactions, and how these alterations lead in turn to dis-regulation of signaling pathways and gene-expression programs. The work described here focuses on oncoproteins in the Wnt signaling pathway, but importantly, the techniques described are widely applicable, and have the potential to provide a powerful means of elucidating protein interaction networks in cancer cells. The broader impacts of this work include the potential identification of novel colorectal cancer therapeutic targets as well as mapping protein networks in cancer cells, so that in future the wider effects of therapeutics in the cancer cell can be better understood.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores